Focus on Clinical Diagnostics: AACC Next Week- ABAX, ALR, CPHD, QDEL,TMO

cheap neurontin 300 mg shipped overnight http://dreamingoutloud.nl/ Diagnostics and Tools Stocks Are At New Highs

We will be attending the American Association of Clinical Chemistry Meeting in Houston next week. Our focus stocks are summarized below and as you can see they have already made huge moves this year.In the past we have seen an “AACC Effect” with significant stock price movements e.g. ABAX, NEOG, QDEL, but  life science stocks are already up 30+% in 2013 the upside may be limited.Here are several of our DX picks and where they stand YTD:

Abaxis (ABAX $51) at 52 week highs.POC testing  for human and vet.

Alere (ALR $29) at 52 week highs. POC leader in turnaround mode.

Cepheid (CPHD $35) off high of $40, core position in molecular DX. Choppy lately.

Exact Sciences (EXAS $13) near all time high of $14.70.Awaiting FDA approval of molecular colorectal screening test.

Hologic (HOLX $22.55) new pick, off bottom. Bought GenProbe last year.

Illumina (ILMN $81.34) new highs, turned down Roche offer in 50’s.

Neogen (NEOG $56.90) off 52 week high of $61.Core position in ag and environmental testing.

Quidel (QDEL $28.60) near 52 week high of $29.75.Rapid tests for infectious diseases.

Qiagen (QGEN $20.72) a laggard, waiting for something to happen.Genetic testing, biomarkers and lab equipment.

Response Genetics (RGDX $2.06) turnaround under way for biomarker cancer testing Company. Stock in turbo mode.

Sequenom (SQNM $3.27) choppy trading over years, bashed by huge miss yesterday down 31%. Company could be sold.

ThermoFisher (TMO $90.72) near 52 week high, large cap core position in tools/dx .

————–

click 2013  Rayno Diagnostics and Tools  *      Prices are as of 7/1/13

2010-2013 Original Price Price % Price Price % RET Price %RET
DX and Tools Recomm Dec’10 Ret 10/2/12 1/2/13 1 yr 7/1/13 YTD
Abaxis ABAX 2/2/09 15 26.9 79 37.9 37.8 36.7 48.36 30.35
BG Medicine BGMD 5/15/13 1.73 NEW 2.32 -58 1.27 -45
CardioV.Sys. CSII 11/5/10 7.15 11.7 63 11.45 13 29.7 21.29 69.64
Celera CRA 3/28/10 7 6.3 18 acquired
Cepheid CPHD 10/23/12 31.4 NEW 35.5 13 34.72 2.54
Exact Sci EXAS 12/10/10 5.6 5.98 6.8 11.36 11 36 14.44 36.36
GenomicH GHDX 2/26/13 28.5 NEW 27.24 6.3 32.85 20.6
GenProbe GPRO 2/2/09 45 58.4 30 82.55 acquired
Hologic HOLX 4/9/13 21.6 NEW 20 19.57 -2.2
Illumina ILMN 2/2/09 29 63.3 118 51.2 55.4 81.8 76.27 37.2
Immucor BLUD 4/5/10 20 19.8 0 acquired
Alere ALR 2/2/09 25 36.6 46 19.64 19 -18 25.05 35.41
MicroFluidics MFLU 7/6/10 0.77 1.34 74 acquired
NeoGen NEOG 7/2/10 26 41 58 42.8 45.6 48.8 56.41 24.47
Qiagen QGEN 3/15/10 21.5 19.6 -9 19 18.8 36 20.05 10.47
Quidel QDEL 6/16/10 12.4 14.5 16 18.65 19.9 31.3 26.45 41.67
ResponseG RGDX 2/3/12 1.5 1.3 1.4 -13 1.52 9.35
Sequenom SQNM 11/18/09 3.75 8.03 114 3.5 4.93 10.8 4.3 -7.64
SeraCare SRLS 11/18/09 2.75 4.75 73 acquired
ThermoFish TMO 7/25/12 53.5 NEW 59.4 65 44.5 86.35 35.4
Vermillion VRML 5/15/13 2.53 NEW 1.37 73 2.65 100.8

* We trade positions and rebalance frequently and currently hold the following stocks: ALR, CPHD, CSII, HOLX, ILMN, RGDX.

 

, , , , , ,

No comments yet.

Leave a Reply